BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Catalent Names Alessandro Maselli President and Chief Operating Officer

  Catalent, Inc. announced that Senior Vice President, Global Operations Alessandro Maselli has been appointed President and Chief Operating Officer, a new position within Catalent.

  February 13, 2019

   · 

  3 min read
• Deals

  Acceleron to Present at Two Upcoming Healthcare Investor Conferences

  Acceleron Pharma Inc., a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics intended to treat serious and rare diseases, announced that senior management will present at two upcoming healthcare investor conferences.

  February 13, 2019

   · 

  1 min read
• Drug Development

  Affinivax, Inc. Announces Initiation of Phase 1/2 Clinical Study of ASP3772, Its Novel Pneumococcal MAPS Vaccine, in Collaboration with Astellas

  Clinical study will evaluate safety, tolerability, and immunogenicity in adults

  February 13, 2019

   · 

  5 min read
• Business

  Charles River Laboratories Announces Fourth-Quarter and Full-Year 2018 Results and Provides 2019 Guidance

  Charles River Laboratories International, Inc. reported its results for the fourth-quarter and full-year 2018 and provided guidance for 2019.

  February 13, 2019

   · 

  33 min read
• Deals

  Charles River Laboratories Signs Binding Offer to Acquire Citoxlab

  Charles River Laboratories International, Inc. announced that it has signed a binding offer to acquire Citoxlab for €448 million in cash, subject to customary closing adjustments.

  February 13, 2019

   · 

  11 min read
• Business

  Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2018 Investor Update

  Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a commercial biotechnology company, today provided an update on its fourth quarter and full year 2018 results and recent business activities.

  February 13, 2019

   · 

  37 min read
• Business

  Teva Reports Fourth Quarter and Full Year 2018 Financial Results

  Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) reported results for the year and the quarter ended December 31, 2018.

  February 13, 2019

   · 

  46 min read
• Mayne Pharma launches Lexette (TM) (halobetasol propionate) foam 0.05% in the United States

  Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the launch of LEXETTE™ (halobetasol propionate) Foam 0.05% in the United States.

  February 13, 2019

   · 

  4 min read
• Business

  NextGate and IDology Partner to Mitigate Patient Identification Risks

  NextGate, the global leader in healthcare enterprise identification, announced today a strategic partnership with IDology, a pioneer and trusted leader in identity verification, authentication and fraud prevention.

  February 13, 2019

   · 

  3 min read
• Drug Development

  Sojournix Announces Positive Top-Line Phase 1 Data Demonstrating Clinical Proof of Mechanism and Once-Daily (QD) Pharmacokinetics for SJX-653

  Sojournix, a clinical stage biopharmaceutical company focused on developing and commercializing novel therapies for the treatment of women’s health and neuroendocrine disorders, today announced positive top-line data from a first-in-human Phase 1 clinical study of SJX-653

  February 13, 2019

   · 

  6 min read